Scientific equipment maker Thermo Fisher Scientific will buy rival Life Technologies Corp. for approximately $13.6 billion in a deal that combines two of the biggest companies in the field of genomics and cell biology.

Thermo Fisher will pay Life Technologies shareholders $76 for each share of stock. Thermo Fisher will also assume about $2.2 billion in debt, bringing the total deal value to about $15.8 billion.